News
24m
HealthDay on MSNFDA Approves Twice-Yearly Yeztugo for Preexposure Prophylaxis to Cut HIV RiskThe U.S. Food and Drug Administration has approved Yeztugo (lenacapavir), an injectable HIV-1 capsid inhibitor, as ...
45m
Everyday Health on MSNFDA Approves a ‘Game-Changing’ Twice-a-Year HIV Prevention ShotThe new HIV PrEP option could drastically reduce the number of new cases by offering a new alternative to daily pills or every-other-month injections.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results